(Q44075173)

29 November 2017

title

Do atypical features affect outcome in depressed outpatients treated with citalopram? (English)

1 reference

29 November 2017

2

1 reference

29 November 2017

Stephen R. Wisniewski

series ordinal

4

1 reference

29 November 2017

12

A John Rush

2 references

ORCID Public Data File 2021

29 November 2017

8

Madhukar H Trivedi

1 reference

29 November 2017

10

Diane Warden

1 reference

29 November 2017

7

Andrew A Nierenberg

1 reference

29 November 2017

5

Sidney Zisook

1 reference

29 November 2017

3

Maurizio Fava

1 reference

29 November 2017

11

Ira Lesser

1 reference

29 November 2017

Jonathan W Stewart

1

1 reference

29 November 2017

Ian Cook

series ordinal

6

1 reference

29 November 2017

G K Balasubramani

series ordinal

9

1 reference

29 November 2017

publication date

3 April 2009

1 reference

The International Journal of Neuropsychopharmacology

29 November 2017

published in

1 reference

29 November 2017

volume

13

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

15-30

1 reference

Comparison of self-report and clinician ratings on two inventories of depressive symptomatology.

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Clinical features of depressed patients who do and do not improve with placebo

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Establishment of Diagnostic Validity in Psychiatric Illness: Its Application to Schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

A comparison of descriptive variables for clinical patients and symptomatic volunteers with depressive disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Psychomotor changes in melancholic and atypical depression: unipolar and bipolar-II subtypes.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Prevalence and clinical features of atypical depression in depressed outpatients: a 467-case study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Atypical depression: clinical aspects and noradrenergic function

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Partial validation of the atypical features subtype of major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

The high prevalence of "soft" bipolar (II) features in atypical depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Toward validation of atypical depression in the community: results of the Zurich cohort study.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

The Psychiatric Diagnostic Screening Questionnaire: development, reliability and validity

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Atypical depressive syndromes in varying definitions.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Atypical depression: a reappraisal

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

A comparative study of neurotic depression in symptomatic volunteers and psychiatric patients.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Fluoxetine versus phenelzine in atypical depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Self-Rated Global Measure of the Frequency, Intensity, and Burden of Side Effects

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Predictors of Relapse in a Prospective Study of Fluoxetine Treatment of Major Depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

A Placebo-Controlled Study of Fluoxetine Versus Imipramine in the Acute Treatment of Atypical Depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Symptomatic volunteers in depression research: a closer look

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Moclobemide and fluoxetine in atypical depression: a double-blind trial.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Outcome definitions and predictors in depression.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Cumulative illness rating scale

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Latent class analysis of lifetime depressive symptoms in the national comorbidity survey

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Antidepressant specificity in atypical depression.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Reversed neurovegetative symptoms of depression: a community study of Ontario.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Efficacy of desipramine in depressed outpatients. Response according to research diagnosis criteria diagnoses and severity of illness

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Clinical and demographic factors associated with DSM-IV melancholic depression.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

The identification and validation of distinct depressive syndromes in a population-based sample of female twins

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Atypical depression: current status and relevance to melancholia.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Depression with atypical features in a sample of primary care outpatients: prevalence, specific characteristics and consequences.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

The validity of major depression with atypical features based on a community study.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Tranylcypromine versus imipramine in anergic bipolar depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

The Inventory of Depressive Symptomatology (IDS): psychometric properties.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

The inventory for depressive symptomatology (IDS): Preliminary findings

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

https://api.crossref.org/works/10.1017%2FS1461145709000182

1 reference

7 January 2021

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

Response, partial response, and nonresponse in primary care treatment of depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145709000182

7 January 2021

10.1017/S1461145709000182

Identifiers

DOI

1 reference

29 November 2017

1 reference